⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CALC News
CalciMedica, Inc. Common Stock
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation
prnewswire.com
CALC
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
prnewswire.com
CALC
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension
prnewswire.com
CALC
CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025
prnewswire.com
CALC
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™
prnewswire.com
CALC